Moreover, PIM-2 levels in CLL correlate with the clinical stage of the disease and to the lymphocyte doubling time, and it was suggested that PIM-2 contributes to the lymphomagenesis by functioning as a survival factor [10]. Here, PIM2 is linked to B-cell chronic lymphocytic leukemia.